biote Corp.
BTMD- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001819253
In the last 90 days, biote Corp. insiders filed 1 open-market purchase and 0 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $24.8M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in biote Corp. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q3 2022
- Shares held
- 1.28M
- −515.0K (−28.7%) vs. Q3 2022
- Total value
- $4.78M
- −$2.91M (−37.8%) vs. Q3 2022
- New holders
- 2
- 4 more added
- Sold out
- 1
- 6 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $24.8M |
| Q1 2026 | 84 | $20.5M |
| Q4 2025 | 85 | $40.9M |
| Q3 2025 | 87 | $46.6M |
| Q2 2025 | 98 | $66.7M |
| Q1 2025 | 90 | $56.4M |
| Q4 2024 | 94 | $116.5M |
| Q3 2024 | 83 | $99.6M |
| Q2 2024 | 75 | $118.0M |
| Q1 2024 | 54 | $69.5M |
| Q4 2023 | 54 | $62.7M |
| Q3 2023 | 54 | $67.4M |
| Q2 2023 | 55 | $88.2M |
| Q1 2023 | 27 | $42.6M |
| Q4 2022 | 16 | $4.78M |
| Q3 2022 | 16 | $7.69M |
| Q2 2022 | 12 | $2.42M |
| Q1 2022 | 1 | $1.50M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding biote Corp.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wasatch Advisors Inc | 412,452 | $1.54M | 0.01% | +317,518+334.5% | Added |
| Venator Capital Management Ltd. | 300,000 | $1.12M | 1.82% | +95,408+46.6% | Added |
| Diametric Capital, LP | 164,468 | $613.5K | 0.30% | +368+0.2% | Added |
| Cohanzick Management, LLC | 121,051 | $451.5K | 0.13% | −721,006−85.6% | Reduced |
| Prelude Capital Management, LLC | 87,526 | $326.5K | 0.02% | −3,828−4.2% | Reduced |
| Boothbay Fund Management, LLC | 75,000 | $279.8K | 0.01% | 00.0% | Unchanged |
| RiverPark Advisors, LLC | 41,085 | $153.2K | 0.07% | −40,206−49.5% | Reduced |
| Meteora Capital, LLC | 28,661 | $106.9K | 0.02% | −66,389−69.8% | Reduced |
| Pitti Group Wealth Management, LLC | 24,600 | $91.8K | 0.11% | 00.0% | Unchanged |
| Creative Planning | 11,599 | $43.3K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 10,000 | $37.0K | 0.00% | −49,907−83.3% | Reduced |
| UBS Group AG | 3,284 | $12.2K | 0.00% | +1,259+62.2% | Added |
| Wolverine Asset Management LLC | 876 | $3.27K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 44 | $164 | 0.00% | +44 | New |
| Morgan Stanley | 5 | $19 | 0.00% | −2,007−99.8% | Reduced |
| Bank of America Corp | 2 | $8 | 0.00% | +2 | New |
| BBR Partners, LLC | 0 | $0 | 0.00% | −46,227−100.0% | Sold out |
| Tilden Park Management I LLC | – | – | – | – | Not filed |